|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US7256216||VIATRIS||Liquid pharmaceutical compositions|| |
(1 year, 4 months ago)
|VIATRIS||Liquid pharmaceutical compositions|| |
(10 months ago)
Neurontin is owned by Viatris.
Neurontin contains Gabapentin.
Neurontin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Neurontin are:
Neurontin was authorised for market use on 02 March, 2000.
Neurontin is available in solution;oral dosage forms.
The generics of Neurontin are possible to be released after 28 November, 2022.
Market Authorisation Date: 02 March, 2000
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic